Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polβ modulates the expression of type I interferon via STING pathway.
Huang M, Wu T, Liu R, Wang M, Shi M, Xin J, Shao S, Zhao X, Ma Y, Gu L, Guo Z, Pan F. Huang M, et al. Among authors: gu l. Biochem Biophys Res Commun. 2022 Sep 17;621:137-143. doi: 10.1016/j.bbrc.2022.07.005. Epub 2022 Jul 2. Biochem Biophys Res Commun. 2022. PMID: 35834922
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.
Chen J, Hu J, Gu L, Ji F, Zhang F, Zhang M, Li J, Chen Z, Jiang L, Zhang Y, Shi R, Ma L, Jia S, Zhang Y, Zhang Q, Liang J, Yao S, Hu Z, Guo Z. Chen J, et al. Among authors: gu l. Cancer Immunol Immunother. 2023 Feb;72(2):409-425. doi: 10.1007/s00262-022-03238-w. Epub 2022 Aug 4. Cancer Immunol Immunother. 2023. PMID: 35925286 Free PMC article.
Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.
Chen J, Hu J, Gu L, Ji F, Zhang F, Zhang M, Li J, Chen Z, Jiang L, Zhang Y, Shi R, Ma L, Jia S, Zhang Y, Zhang Q, Liang J, Yao S, Hu Z, Guo Z. Chen J, et al. Among authors: gu l. Cancer Immunol Immunother. 2023 Oct;72(10):3401-3403. doi: 10.1007/s00262-023-03510-7. Cancer Immunol Immunother. 2023. PMID: 37578659 Free PMC article. No abstract available.
Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE-/- mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway.
Gu L, Ye P, Li H, Wang Y, Xu Y, Tian Q, Lei G, Zhao C, Gao Z, Zhao W, Tan S. Gu L, et al. FASEB J. 2019 Apr;33(4):4836-4850. doi: 10.1096/fj.201802251R. Epub 2019 Jan 2. FASEB J. 2019. PMID: 30601695
Lunasin may act as a potential therapeutic agent for the prevention and treatment of atherosclerosis.-Gu, L., Ye, P., Li, H., Wang, Y., Xu, Y., Tian, Q., Lei, G., Zhao, C., Gao, Z., Zhao, W., Tan, S. ...
Lunasin may act as a potential therapeutic agent for the prevention and treatment of atherosclerosis.-Gu, L., Ye, P., Li, H., …
6,557 results